Učitavanje...
A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder
BACKGROUND: Since about one-third of patients with major depressive disorder (MDD) do not respond adequately to available antidepressants, there is a need for treatments based on novel mechanisms of action. Neuropeptide Y (NPY), a normal brain constituent, is reduced in cerebrospinal fluid of patien...
Spremljeno u:
| Izdano u: | Int J Neuropsychopharmacol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7770516/ https://ncbi.nlm.nih.gov/pubmed/33009815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyaa054 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|